Volume 21, Issue 1 (5-2007)                   Med J Islam Repub Iran 2007 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Yassaee V, Dalton A. Gene assembling: a new approach in molecular diagnosis of hereditary breast cancer. Med J Islam Repub Iran. 2007; 21 (1) :29-37
URL: http://mjiri.iums.ac.ir/article-1-272-en.html
Genomic Research Center Shahid Beheshti University of Medical Sciences, Koodakyar St., Daneshjoo Blvd,Velenjak Ave., Tehran, Iran. , vahid_r_yassaee@hotmail.com
Abstract:   (4989 Views)


 Background: Many disease susceptibility genes are large and consist of many exons in which point mutations are scattered throughout. Scanning each exon individually represents a tedious task which can be time consuming and expensive. There has been increasing demand for rapid and accurate methods for full scanning of unknown point mutations in large multi-exon genes. Gene Assembling is a new method for creating chimeric DNA molecules using a modified PCR reaction that allows maximizing the length of sequence that can be scanned by sensitive downstream technique.

 Methods: In the present study assembling of exons 2, 20, 23 and 24 of the BRCA1 gene and their subsequent analysis by direct sequencing is demonstrated. The BRCA1 exons 2 and 20 are hot spot regions that are known to harbor particularly deleterious mutations. In order to avoid missing any mutation in these two exons, the four exons previously mentioned were assembled in the following order of preferences: 23, 20, 2 and 24. However, the order of fragments can be predetermined by primer design.

 Results: The order and sequence of the component exons in the gene-assembled products were characterized by direct sequencing as predicted. Gene-assembled products from three previously ascertained heterozygotes for BRCA1 mutations were directly sequenced and gave the same sequence patterns.

 Conclusion: This experience suggests that Gene Assembling technique could be applied as a highly sensitive and cost-effective method in identifying mutation in complex genes such as BRCA and ColA1/2 helping clinical molecular diagnostic laboratories, to fulfill the demand for scanning complex genetic diseases at a lower cost.

Full-Text [PDF 601 kb]   (1065 Downloads)    
Type of Study: Original Research | Subject: Special

Add your comments about this article : Your username or Email:
Write the security code in the box

Send email to the article author